Helvetica Chimica Acta – Vol. 93 (2010)
45
3308. 1H-NMR: 1.9 (s, 3 H); 4.25 (d, J ¼ 6.0, 2 H); 7.59 (d, J ¼ 8.7, 2 H); 7.77 (d, J ¼ 8.7, 2 H). 13C-NMR:
22.7; 29.7 81.1; 91.9; 112.5; 118.9; 128.7; 133.1; 169.8. GLC/MS: 198, 183, 155 (100). Anal. calc. for
C12H10N2O (198.22): C 72.71, H 5.08, N 14.13; found: C 71.63, H 4.96, N 13.37.
N-[3-(2-Chlorophenyl)prop-2-yn-1-yl]acetamide. According to the G.P.1, with polymer-bound
propargylamine (1006 mg, 0.74 mmol/g), 1-chloro-2-iodobenzene (460 ml, 898 mg, 4.32 mmol), CuI
(60.5 mg, 0.318 mmol), and [Pd(PPh3)2]Cl2 (108 mg, 0.154 mmol) for 18 h. Cleavage (815 mg) and
acetylation according to the G.P.2 followed by CC (SiO2, hexane/AcOEt 1:4) gave the product (68.3 mg,
55%). Yellow crystals. M.p. 106 – 1088. Rf 0.42 (acetone/AcOEt 1:4). FT-IR: 669, 758, 1063, 1278, 1544,
1633, 3294. 1H-NMR: 1.95 (s, 3 H); 4.28 (d, J ¼ 5.4, 2 H); 7.28 – 7.40 (m, 2 H); 7.45 – 7.52 (m, 2 H); 7.6 – 7.7
(br., NH). 13C-NMR: 22.7; 29.7; 76.2; 92.8; 123.5; 127.8; 130.1; 130.6; 134.4; 169.8. GLC/MS: 209, 207
(100), 166, 164, 130, 101. Anal. calc. for C11H10ClNO (207.66): C 63.62, H 4.85, N 6.75; found: C 63.53, H
5.08, N 6.55.
N-[3-(3-Bromophenyl)prop-2-yn-1-yl]acetamide. According to the G.P.1, with polymer-bound
propargylamine (815 mg, 1.1 mmol/g), 1-bromo-3-iodobenzene (340 ml, 754 mg, 2.67 mmol), CuI
(77.8 mg, 0.409 mmol), and [Pd(PPh3)2]Cl2 (120 mg, 0.171 mmol) for 22 h. Cleavage (770 mg) and
acetylation according to the G.P.2 followed by CC (SiO2, AcOEt, acetone/AcOEt 1:5) gave the product
(117 mg, 55%). Yellow crystals. M.p. 89 – 918. Rf 0.42 (acetone/AcOEt 1:4). FT-IR: 678, 773, 1242, 1294,
1558, 1636, 3065, 3249. 1H-NMR: 1.93 (s, 3 H); 4.21 (d, J ¼ 5.7, 2 H); 7.28 – 7.42 (m, 3 H); 7.52 – 7.57 (m,
1 H). 13C-NMR: 22.7; 29.6; 80.9; 89.0; 122.6; 126.1; 131.18; 131.25; 132.3; 134.8; 169.8. GLC/MS: 253, 251,
238, 236, 210, 208 (100), 130, 102, 75. Anal. calc. for C11H10BrNO (252.11): C 52.41, H 4.00, N 5.56; found:
C 52.17, H 3.79, N 5.28.
N-[3-(3-Formylphenyl)prop-2-yn-1-yl]acetamide. According to the G.P.1, with polymer-bound
propargylamine (808 mg, 1.1 mmol/g), 3-iodobenzaldehyde (633 mg, 2.73 mmol), CuI (72.4 mg,
0.380 mmol), and [Pd(PPh3)2]Cl2 (120 mg, 0.171 mmol) for 22 h. After cleavage (777 mg) according to
the G.P.2, and concentration, the residue was cooled to ꢀ 1008 in a liq. N2/EtOH bath, and Ac2O (1.0 ml),
N,N-diisopropylethylamine (1.0 ml), and a cat. amount of DMAP were added. The mixture was stirred in
the cooling bath from ꢀ 1008 to r.t. for 22 h. After evaporation with EtOH (2 ꢂ 10 ml), the residue was
subjected to CC (SiO2, hexane/AcOEt 1:2, AcOEt, acetone/AcOEt 1:10) gradient to give the product
(76.1 mg, 44%). Red-brown oil. Rf 0.37 (acetone/AcOEt 1:4). FT-IR: 685, 1160, 1282, 1542, 1656, 1700,
3063, 3281. 1H-NMR: 1.9 (s, 3 H); 4.25 (d, J ¼ 5.4, 2 H); 7.54 – 7.74 (m, 3 H); 7.87 – 7.93 (m, 1 H); 10.0 (s,
1 H). 13C-NMR: 22.7; 29.7; 81.3; 88.8; 124.9; 129.7; 130.3; 133.2; 137.6; 137.8; 170.0; 192.4. GLC/MS: 201
(100), 186, 158, 130, 77. Anal. calc. for C12H11NO2 (201.22): C 71.63, H 5.51, N 6.96; found: C 69.22, H 5.08,
N 6.36.
N-[3-(4-Fluorophenyl)prop-2-yn-1-yl]acetamide. According to the G.P.1, with polymer-bound
propargylamine (811 mg, 1.1 mmol/g), 1-fluoro-4-iodobenzene (510 ml, 982 mg, 4.42 mmol), CuI
(69.6 mg, 0.365 mmol), and [Pd(PPh3)2]Cl2 (120 mg, 0.171 mmol) for 24 h. Cleavage (762 mg) and
acetylation according to the G.P.2 followed by CC (SiO2, AcOEt) gave the product (24.1 mg, 15%). Pale
yellow crystals. M.p. 1058. Rf 0.41 (acetone/AcOEt 1:4). FT-IR: 728, 817, 817, 840, 1094, 1221, 1507, 1547,
1646, 3296. 1H-NMR: 1.91 (s, 3 H); 4.18 (d, J ¼ 5.4, 2 H); 7.09 – 7.18 (m, 2 H); 7.42 – 7.49 (m, 2 H).
13C-NMR (o, m, p, ipso with respect to F): 22.7; 29.5; 81.4; 87.0; 116.5 (d, 2J(Co,F) ¼ 22.2); 120.3 (d,
4J(Cp,F) ¼ 3.4); 134.5 (d, 3J(Cm,F) ¼ 8.3); 163.3 (d, 1J(Cipso,F) ¼ 245.9); 169.7. GLC/MS: 191, 176, 148
(100), 133. Anal. calc. for C11H10FNO (191.20): C 69.10, H 5.27, N 7.33; found: C 67.44, H 4.56, N 6.95.
N-[3-(Pyridin-3-yl)prop-2-yn-1-yl]acetamide. According to the G.P.1, with polymer-bound prop-
argylamine (804 mg, 1.1 mmol/g), 3-iodopyridine (547 mg, 2.67 mmol), CuI (85.5 mg, 0.449 mmol), and
[Pd(PPh3)2]Cl2 (121 mg, 0.172 mmol) for 22 h. Cleavage (762 mg) and acetylation according to the G.P.2
followed by CC (SiO2, acetone/AcOEt 1:2) gave the product (67.6 mg, 47%). Dark red oil. Rf 0.19
(acetone/AcOEt 1:4). FT-IR: 705, 1286, 1409, 1545, 1657, 3057, 3266. 1H-NMR: 1.95 (s, 3 H); 4.25 (d, J ¼
5.4, 2 H); 7.37 (ddd, J ¼ 0.9, 4.8, 7.8, 1 H); 7.78 (td, J ¼ 1.8, 8.1, 1 H); 8.54 (dd, J ¼ 1.7, 5.0, 1 H); 8.59 (d, J ¼
1.5, 1 H). 13C-NMR: 22.7; 29.7; 79.4; 90.7; 120.8; 124.1; 139.2; 149.6; 152.8; 169.9. GLC/MS: 174, 159, 131
(100), 105, 104, 79. Anal. calc. for C10H10N2O (174.20): C 68.95, H 5.79, N 16.08; found: C 66.00, H 5.88, N
14.78.
N-[3-(3-Chlorophenyl)prop-2-yn-1-yl]acetamide. According to the G.P.1, with polymer-bound
propargylamine (806 mg, 1.1 mmol/g), 1-chloro-3-iodobenzene (550 ml, 1060 mg, 4.45 mmol), CuI